![Jasper Therapeutics, Inc. logo](/logos/JSPR.webp)
Jasper Therapeutics, Inc.
NASDAQ:JSPR
Overview | Financials
Company Name | Jasper Therapeutics, Inc. |
Symbol | JSPR |
Currency | USD |
Price | 18.63 |
Market Cap | 281,411,739 |
Dividend Yield | 0% |
52-week-range | 4 - 31.01 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ronald A. Martell |
Website | https://jaspertherapeutics.com |
An error occurred while fetching data.
About Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD